What happens when the thing you’ve loved since you were a kid, the thing that led you to become an 11-time NBA All-star, and two-time champion, playing alongside the best in the world, comes to a cataclysmic end at the age of 31? Leaving you to figure out what to do with the rest of your life? That is exactly what happened to this week’s guest, Chris Bosh. He fell in love with basketball at an early age and earned the prestigious “Mr. Basketball” title while still in high school in Dallas, Texas. A year into college, Chris was drafted to the Toronto Raptors, where he played for 7 years, before joining the Miami Heat and winning two championships. But, a handful of years into his time in Miami, he was having trouble breathing and found himself in the hospital with blood clots in his lungs. A year later, the clots returned in his leg, officially ending his career, and launching him into an exploration of who he was, beyond the sport that had defined much of his life and his career. Chris shared many of his awakenings in his new memoir, Letters to a Young Athlete (https://amzn.to/3wrUfi4).You can find Chris at:Website : https://www.chrisbosh.com/Instagram : https://www.instagram.com/chrisbosh/If you LOVED this episode:You’ll also love the conversations we had with rock icon, Peter Frampton about his profound passion for guitar that led to an album and career taking him to the top of the charts for year, but then leaving him to reimagine who he wanted to be in the context of an industry that pulled him to be someone else : https://tinyurl.com/GLPpeterframpton-------------Have you discovered your Sparketype yet? Take the Sparketype Assessment™ now. IT’S FREE (https://sparketype.com/) and takes about 7-minutes to complete. At a minimum, it’ll open your eyes in a big way. It also just might change your life.If you enjoyed the show, please share it with a friend. Thank you to our super cool brand partners. If you like the show, please support them - they help make the podcast possible. See acast.com/privacy for privacy and opt-out information.